The researchers achieve this by examining the genetic material in patients with presumed genetically based epilepsy and their families using the computational capacity of the Danish National Genome Center's supercomputer to perform advanced statistical analyses on sequence data collected through whole genome sequencing, exome sequencing, and nanopore sequencing.